Dear colleagues,
Lung cancer is the leading cause of cancer related deaths among men and women in USA. Significant advances have been made in the screening for lung cancer, diagnosis and treatment during the past decade. With reduction in the incidence of smoking the incidence of lung cancer among men has been decreasing in the US. In addition with early diagnosis, advances in the treatment has impacted overall survival. Minimally invasive techniques for diagnosis, staging and surgical resection has reduced the morbidity and mortality associated with these as well as targeted personalized approach guided by molecular markers is increasingly used. Even among patients with advanced disease innovative therapy appear to lead to a chronic course of this disease even in the advanced cancer stages. Multidisciplinary approach to the care is critical. In this special issue of the Journal we will address recent advances in the diagnosis and treatment of lung cancer.
Proposed Topics:
1. Lang cancer screening
2. Establishing diagnosis
3. Gender in epidemiology and outcomes
4. Pathology and molecular markers
5. Surgery in the diagnosis and treatment
6. Radiation for limited and advance cancer
7. Chemotherapy and immunotherapy
8. Use of complementary and alternative medicine
9. Supportive and palliative care
Dr. Wickii T. Vigneswaran
Guest Editor
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.
- Open Access ReviewMolecular Markers in Guiding Lung Cancer Diagnosis and TreatmentVivian Li, Wickii T. VigneswaranJ. Mens. Health 2022, 18(8), 164; https://doi.org/10.31083/j.jomh1808164(This article belongs to the Special Issue Lung Cancer: The Changing Paradigm)2Download81Views
- Open Access Original ResearchPrecision radiotherapy by SPECT lung functional imaging in NSCLCCarlo Greco, Michele Fiore, Venanzio Valenza, Cristina Di Venanzio, ... Sara RamellaJ. Mens. Health 2022, 18(4), 101; https://doi.org/10.31083/j.jomh1804101(This article belongs to the Special Issue Lung Cancer: The Changing Paradigm)23Download61Views
- Open Access ReviewEpidemiology of lung cancer and the gender differences in riskMark Jaradeh, Wickii T. VigneswaranJ. Mens. Health 2022, 18(3), 73; https://doi.org/10.31083/j.jomh1803073(This article belongs to the Special Issue Lung Cancer: The Changing Paradigm)25Download99Views